AEON Biopharma, Inc.
AEON
$0.6902
$0.00020.03%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -173.03% | 336.84% | 133.74% | -103.76% | 239.06% |
| Total Depreciation and Amortization | 5.26% | -17.39% | -8.00% | 4.17% | -4.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.62% | -86.23% | -259.79% | 102.21% | -255.67% |
| Change in Net Operating Assets | 109.24% | -276.33% | 671.06% | 72.63% | -2,295.83% |
| Cash from Operations | 73.56% | -1,173.59% | 78.98% | 63.59% | 5.63% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.54% | 18,813.40% | 94.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.54% | 18,813.40% | 94.00% | -99.50% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.24% | 2,091.03% | 81.96% | -254.19% | 152.33% |